Juan Vicente Llau
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Juan Vicente Llau has a total of 341 co-authors. Here are the top co-authors by number of shared publications:
- Raquel Ferrandis
Servicio de Anestesiología y Reanimación, Hospital Universitari i Politècnic La Fe, Valencia, España
14 shared publications - María José Colomina
Department of Anesthesiology, Bellvitge University Hospital, 08907 L’Hospitalet de Llobregat, Spain
8 shared publications A. Gómez-Luque
Sociedad Española de Anestesiología-Reanimación y Terapéutica del Dolor (SEDAR), Spain; Hospital Universitario Virgen de la Victoria, Málaga, Spain
6 shared publications- Jose Antonio Paramo
Servicio de Hematología y Hemoterapia, Clínica Universidad de Navarra, Pamplona, España
6 shared publications - José Antonio García-Erce
Banco de Sangre y Tejidos de Navarra, Pamplona, Navarra, España; Aragón Health Research Institute (IACS), Aragon Institute for Health Research (IIS Aragon), Zaragoza; Grupo Español de Rehabilitación Multimodal (GERM), Zaragoza, España; Grupo de Investigación Gestión en el Paciente Sangrante-PBM, Instituto de Investigación Sanitaria, Hospital Universitaria La Paz (IdiPAZ), Madrid, España
6 shared publications M. Quintana
Sociedad Española de Medicina Intensiva, Crítica y de Unidades Coronarias (SEMICYUC), Spain; Hospital Universitario La Paz-Carlos III, Madrid, Spain
6 shared publications
Latest Publications
- Open Access
- 1 August 2026
- Published by Wiley in Transfusion
- Vol. 66 (10) , 1963-1973
Transfusion intensity in the ICU : Reasons and triggers
Background: The reasons and physiological triggers for blood transfusion in critically ill patients are not well characterized. Beyond hemoglobin levels, hemodynamic instability is frequently cited, but its role across clinical contexts remains unclear. Aims: (1) To determine whether reasons and triggers for RBC transfusion differ across intensive care unit (ICU) days with varying transfusion intensity. (2) To describe reasons for non‐RBC transfusions across these intensity groups. Methods: This sub‐study of the prospective International Point Prevalence Study of Intensive Care Unit Transfusion Practices (InPUT) classified ICU days by transfusion intensity: nonmajor (1 RBC unit), major (≥2 units), and massive (≥6 units in a single event, ≥10 per day, or Massive Transfusion Protocol activation). ICU days without transfusion for active bleeding were classified as no bleeding. Results: Significant differences in the multivariate composition of reasons for RBC transfusion were observed across intensity groups on permutational analysis of variance (PERMANOVA). Hypotension was the most frequently cited physiological trigger in nonmajor (54%, n = 80/148) and major transfusions (68%, n = 196/288), but less frequent in massive transfusions (30%, n = 14/64). Tachycardia was the second most common trigger in nonmajor (37%, n = 80/148), major (40%, n = 116/288), and massive transfusions (22%, n = 19/64). Conclusion: RBC transfusions are administered for distinct, intensity‐dependent combinations of reasons and triggers. Transfusion intensity and clinical context are therefore key factors in evaluating transfusion practices. Among bleeding critically ill patients, hypotension and tachycardia are the most frequently cited physiological triggers.
- 1 August 2026
- Published by Wiley in Transfusion
- Vol. 66 (10) , 1963-1973
Open AccessTransfusion intensity in the ICU : Reasons and triggers
Background: The reasons and physiological triggers for blood transfusion in critically ill patients are not well characterized. Beyond hemoglobin levels, hemodynamic instability is frequently cited, but its role across clinical contexts remains unclear. Aims: (1) To determine whether reasons and triggers for RBC transfusion differ across intensive care unit (ICU) days with varying transfusion intensity. (2) To describe reasons for non‐RBC transfusions across these intensity groups. Methods: This sub‐study of the prospective International Point Prevalence Study of Intensive Care Unit Transfusion Practices (InPUT) classified ICU days by transfusion intensity: nonmajor (1 RBC unit), major (≥2 units), and massive (≥6 units in a single event, ≥10 per day, or Massive Transfusion Protocol activation). ICU days without transfusion for active bleeding were classified as no bleeding. Results: Significant differences in the multivariate composition of reasons for RBC transfusion were observed across intensity groups on permutational analysis of variance (PERMANOVA). Hypotension was the most frequently cited physiological trigger in nonmajor (54%, n = 80/148) and major transfusions (68%, n = 196/288), but less frequent in massive transfusions (30%, n = 14/64). Tachycardia was the second most common trigger in nonmajor (37%, n = 80/148), major (40%, n = 116/288), and massive transfusions (22%, n = 19/64). Conclusion: RBC transfusions are administered for distinct, intensity‐dependent combinations of reasons and triggers. Transfusion intensity and clinical context are therefore key factors in evaluating transfusion practices. Among bleeding critically ill patients, hypotension and tachycardia are the most frequently cited physiological triggers.
- Open Access
- 8 April 2026
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 54 (7) , 1667-1679
The Influence of Older Age on RBC Transfusion Decisions in ICU Patients
Objectives: RBC transfusions are common in the ICU. Recent studies suggest that a restrictive transfusion policy is noninferior or superior to a liberal policy. However, few studies focus on the influence of age in transfusion. In elderly ICU patients, reduced physiologic reserves may shift the perceived risk-benefit balance of transfusion, potentially leading to different transfusion practices. This study examines whether transfusion practices in ICU patients differ across patient age. Design: This is a substudy of the International Point Prevalence Study of ICU Transfusion Practices (InPUT), a global, multicenter, prospective observational cohort study. Setting: ICUs from 233 centers across 30 countries. Data were collected from March 2019 to October 2022 in prespecified weeks. Patients: Adult ICU patients (≥ 18 yr) admitted during predefined study weeks. Patients were categorized by age (< 65, 65–75, 75–85, and > 85 yr). Interventions: None. Measurements and Main Results: A total of 3643 patients from 233 centers across 30 countries were included. Of these, 53% were younger than 65 years, 26% were 65–75 years, 17% were 75–85 years, and 4% were older than 85 years. RBC transfusion rates ranged from 23% to 26% across all age groups ( p = 0.91). Patients older than 85 years had higher stated hemoglobin thresholds (median, 10.0 g/dL) compared with younger patients (median, 8.0 g/dL; p < 0.001). “Age” and “improve general state” were more frequently cited as reasons for transfusion in patients older than 85 years. However, after adjustment, age was not associated with the probability of receiving an RBC transfusion. Conclusions: Different transfusion strategies are applied in patients older than 85 years old. These differences appear to be driven by age-related differences in physiology and diagnoses rather than motivated by older age itself.
- 8 April 2026
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 54 (7) , 1667-1679
Open AccessThe Influence of Older Age on RBC Transfusion Decisions in ICU Patients
Objectives: RBC transfusions are common in the ICU. Recent studies suggest that a restrictive transfusion policy is noninferior or superior to a liberal policy. However, few studies focus on the influence of age in transfusion. In elderly ICU patients, reduced physiologic reserves may shift the perceived risk-benefit balance of transfusion, potentially leading to different transfusion practices. This study examines whether transfusion practices in ICU patients differ across patient age. Design: This is a substudy of the International Point Prevalence Study of ICU Transfusion Practices (InPUT), a global, multicenter, prospective observational cohort study. Setting: ICUs from 233 centers across 30 countries. Data were collected from March 2019 to October 2022 in prespecified weeks. Patients: Adult ICU patients (≥ 18 yr) admitted during predefined study weeks. Patients were categorized by age (< 65, 65–75, 75–85, and > 85 yr). Interventions: None. Measurements and Main Results: A total of 3643 patients from 233 centers across 30 countries were included. Of these, 53% were younger than 65 years, 26% were 65–75 years, 17% were 75–85 years, and 4% were older than 85 years. RBC transfusion rates ranged from 23% to 26% across all age groups ( p = 0.91). Patients older than 85 years had higher stated hemoglobin thresholds (median, 10.0 g/dL) compared with younger patients (median, 8.0 g/dL; p < 0.001). “Age” and “improve general state” were more frequently cited as reasons for transfusion in patients older than 85 years. However, after adjustment, age was not associated with the probability of receiving an RBC transfusion. Conclusions: Different transfusion strategies are applied in patients older than 85 years old. These differences appear to be driven by age-related differences in physiology and diagnoses rather than motivated by older age itself.
- Open Access
- 25 September 2025
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 53 (12) , e2526-e2539
Platelet Transfusion Practices in the ICU: A Prospective Multicenter Cohort Study
Objective: There is a lack of comprehensive international data regarding platelet transfusion practices in the ICU. This study aimed to evaluate the current occurrence rate of platelet transfusion in the ICU and provide an overview of platelet transfusion practices including indications for a platelet transfusion, thresholds, (non-)adherence and geo-economic region variations. Design: International prospective cohort study. Setting: Two hundred thirty-three centers in 30 countries worldwide. Patients: All patients 18 years old and older, admitted to the ICU during a single study week, selected by each site from one of the 16 predefined weeks (March 2019 to October 2022), were included. Interventions: None. Measurements and Main Results: Of the 3643 patients, 208 (6%) received a platelet transfusion during their ICU stay and main indications consisted of active bleeding (42%, n = 187/443), prophylaxis (33%, n = 144/443) or an upcoming procedure (12%, n = 51/443). The median platelet count before transfusion was 44 × 10 9 /L (interquartile range [IQR], 20–78) with variation by indication, including a higher median of 60 × 10 9 /L (IQR 31–93) during active bleeding. A threshold for transfusion was stated in 51% ( n = 224/443) of the events, with a median threshold platelet count of 50 × 10 9 /L (IQR, 40–100). The advised threshold was not adhered to in 16% ( n = 36/224) of cases, with the majority having active bleeding as indication. Contrasts in transfusion practices were observed across different geo-economic regions. Platelet transfusions were administered to 6% ( n = 156/2520) of patients in high-income countries, 5% ( n = 52/1069) of patients in upper-middle-income countries and in none from lower-middle-income countries ( n = 0/54). Non-adherence was higher in the high-income countries (23%, n = 34/149) than upper-middle-income countries (3%, n = 2/75). Conclusions: Platelet transfusions were administered to a small proportion of critically ill patients, and were given to treat active bleeding or as prophylaxis in the majority of cases. Occurence rate, indication and threshold adherence for platelet transfusion widely varied between geo-economic regions.
- 25 September 2025
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 53 (12) , e2526-e2539
Open AccessPlatelet Transfusion Practices in the ICU: A Prospective Multicenter Cohort Study
Objective: There is a lack of comprehensive international data regarding platelet transfusion practices in the ICU. This study aimed to evaluate the current occurrence rate of platelet transfusion in the ICU and provide an overview of platelet transfusion practices including indications for a platelet transfusion, thresholds, (non-)adherence and geo-economic region variations. Design: International prospective cohort study. Setting: Two hundred thirty-three centers in 30 countries worldwide. Patients: All patients 18 years old and older, admitted to the ICU during a single study week, selected by each site from one of the 16 predefined weeks (March 2019 to October 2022), were included. Interventions: None. Measurements and Main Results: Of the 3643 patients, 208 (6%) received a platelet transfusion during their ICU stay and main indications consisted of active bleeding (42%, n = 187/443), prophylaxis (33%, n = 144/443) or an upcoming procedure (12%, n = 51/443). The median platelet count before transfusion was 44 × 10 9 /L (interquartile range [IQR], 20–78) with variation by indication, including a higher median of 60 × 10 9 /L (IQR 31–93) during active bleeding. A threshold for transfusion was stated in 51% ( n = 224/443) of the events, with a median threshold platelet count of 50 × 10 9 /L (IQR, 40–100). The advised threshold was not adhered to in 16% ( n = 36/224) of cases, with the majority having active bleeding as indication. Contrasts in transfusion practices were observed across different geo-economic regions. Platelet transfusions were administered to 6% ( n = 156/2520) of patients in high-income countries, 5% ( n = 52/1069) of patients in upper-middle-income countries and in none from lower-middle-income countries ( n = 0/54). Non-adherence was higher in the high-income countries (23%, n = 34/149) than upper-middle-income countries (3%, n = 2/75). Conclusions: Platelet transfusions were administered to a small proportion of critically ill patients, and were given to treat active bleeding or as prophylaxis in the majority of cases. Occurence rate, indication and threshold adherence for platelet transfusion widely varied between geo-economic regions.
- 10 July 2024
- Published by Wolters Kluwer Health in European Journal of Anaesthesiology
- Vol. 41 (8) , 582-588
European guidelines on peri-operative venous thromboembolism prophylaxis: first update.
- 10 July 2024
- Published by Wolters Kluwer Health in European Journal of Anaesthesiology
- Vol. 41 (8) , 582-588
European guidelines on peri-operative venous thromboembolism prophylaxis: first update.
- Open Access
- 12 September 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (18) , 5930
Role of Crystalloids in the Perioperative Setting: From Basics to Clinical Applications and Enhanced Recovery Protocols
Perioperative fluid management, a critical aspect of major surgeries, is characterized by pronounced stress responses, altered capillary permeability, and significant fluid shifts. Recognized as a cornerstone of enhanced recovery protocols, effective perioperative fluid management is crucial for optimizing patient recovery and preventing postoperative complications, especially in high-risk patients. The scientific literature has extensively investigated various fluid infusion regimens, but recent publications indicate that not only the volume but also the type of fluid infused significantly influences surgical outcomes. Adequate fluid therapy prescription requires a thorough understanding of the physiological and biochemical principles that govern the body’s internal environment and the potential perioperative alterations that may arise. Recently published clinical trials have questioned the safety of synthetic colloids, widely used in the surgical field. A new clinical scenario has arisen in which crystalloids could play a pivotal role in perioperative fluid therapy. This review aims to offer evidence-based clinical principles for prescribing fluid therapy tailored to the patient’s physiology during the perioperative period. The approach combines these principles with current recommendations for enhanced recovery programs for surgical patients, grounded in physiological and biochemical principles.
- 12 September 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (18) , 5930
Open AccessRole of Crystalloids in the Perioperative Setting: From Basics to Clinical Applications and Enhanced Recovery Protocols
Perioperative fluid management, a critical aspect of major surgeries, is characterized by pronounced stress responses, altered capillary permeability, and significant fluid shifts. Recognized as a cornerstone of enhanced recovery protocols, effective perioperative fluid management is crucial for optimizing patient recovery and preventing postoperative complications, especially in high-risk patients. The scientific literature has extensively investigated various fluid infusion regimens, but recent publications indicate that not only the volume but also the type of fluid infused significantly influences surgical outcomes. Adequate fluid therapy prescription requires a thorough understanding of the physiological and biochemical principles that govern the body’s internal environment and the potential perioperative alterations that may arise. Recently published clinical trials have questioned the safety of synthetic colloids, widely used in the surgical field. A new clinical scenario has arisen in which crystalloids could play a pivotal role in perioperative fluid therapy. This review aims to offer evidence-based clinical principles for prescribing fluid therapy tailored to the patient’s physiology during the perioperative period. The approach combines these principles with current recommendations for enhanced recovery programs for surgical patients, grounded in physiological and biochemical principles.
- 1 August 2023
- Published by Elsevier in Medicina Intensiva (English Edition)
- Vol. 47 (8) , 454-467
Multidisciplinary consensus document on the management of massive haemorrhage. First update 2023 (document HEMOMAS-II)
- 1 August 2023
- Published by Elsevier in Medicina Intensiva (English Edition)
- Vol. 47 (8) , 454-467
Multidisciplinary consensus document on the management of massive haemorrhage. First update 2023 (document HEMOMAS-II)
- Open Access
- 22 March 2022
- Published by Elsevier in Revista Española de Anestesiología y Reanimación
- Vol. 70 (3) , 129-139
Eficacia de la tromboprofilaxis con heparina de bajo peso molecular en pacientes críticos con COVID-19: estudio observacional, prospectivo y multicéntrico
- 22 March 2022
- Published by Elsevier in Revista Española de Anestesiología y Reanimación
- Vol. 70 (3) , 129-139
Open AccessEficacia de la tromboprofilaxis con heparina de bajo peso molecular en pacientes críticos con COVID-19: estudio observacional, prospectivo y multicéntrico
- 25 October 2021
- Published by Elsevier in Medicina Intensiva (English Edition)
- Vol. 45 (9) , 567-568
SEDAR-SEMICYUC consensus on the management of haemostasis disorders in severe COVID-19 patients
- 25 October 2021
- Published by Elsevier in Medicina Intensiva (English Edition)
- Vol. 45 (9) , 567-568
SEDAR-SEMICYUC consensus on the management of haemostasis disorders in severe COVID-19 patients
- 1 August 2020
- Published by Elsevier in Revista Española de Anestesiología y Reanimación
- Vol. 67 (7) , 391-399
Recomendaciones de consenso SEDAR-SEMICYUC sobre el manejo de las alteraciones de la hemostasia en los pacientes graves con infección por COVID-19
- 1 August 2020
- Published by Elsevier in Revista Española de Anestesiología y Reanimación
- Vol. 67 (7) , 391-399
Recomendaciones de consenso SEDAR-SEMICYUC sobre el manejo de las alteraciones de la hemostasia en los pacientes graves con infección por COVID-19
- Open Access
- 11 June 2020
- Published by Springer Nature in Critical Care
- Vol. 24 (1) , 1-3
COVID-19: opening a new paradigm in thromboprophylaxis for critically ill patients?
- 11 June 2020
- Published by Springer Nature in Critical Care
- Vol. 24 (1) , 1-3
Open AccessCOVID-19: opening a new paradigm in thromboprophylaxis for critically ill patients?